Molecular Biosystems slims workforce to cut costs
This article was originally published in Clinica
Executive Summary
Ultrasound contrast agent development company Molecular Biosystems is to cut its workforce from 140 to 100 as the first stage in a series of measures to cut costs and preserve capital. Further cuts are envisaged once the company begins out-sourcing its manufacturing operations.